Profil
Fa Liu is associated with Focus-X Therapeutics, Inc. as the Chief Executive Officer & Director since 2020.
Dr. Liu is the founder of Focus-X Therapeutics, Inc. which was founded in 2020.
Aktive Positionen von Fa Liu
| Unternehmen | Position | Beginn |
|---|---|---|
Focus-X Therapeutics, Inc.
 Focus-X Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Full-Life Technologies Ltd., Focus-X Therapeutics, Inc. develops radio pharmaceuticals for cancer treatment. The company is based in Watchung, NJ. The company was founded in 2020 by Qi Hui, Fa Liu. Fa Liu has been the CEO since 2020. Focus-X Therapeutics was acquired by Full-Life Technologies Ltd. on March 31, 2023 for $245 million. | Gründer | 01.01.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Focus-X Therapeutics, Inc.
Focus-X Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Full-Life Technologies Ltd., Focus-X Therapeutics, Inc. develops radio pharmaceuticals for cancer treatment. The company is based in Watchung, NJ. The company was founded in 2020 by Qi Hui, Fa Liu. Fa Liu has been the CEO since 2020. Focus-X Therapeutics was acquired by Full-Life Technologies Ltd. on March 31, 2023 for $245 million. | Health Technology |
